Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score.

ABSTRACT:

Purpose

The decision to start venovenous extracorporeal membrane oxygenation (VV ECMO) is commonly based on the severity of respiratory failure, with little consideration of the extrapulmonary organ function. The aim of the study was to identify predictors of mortality and to develop a score allowing a better stratification of patients at the time of VV ECMO initiation.

Methods

This was a prospective multicenter cohort study on 60 patients with influenza A (H1N1)-associated respiratory distress syndrome participating in the Italian ECMOnet data set in the 2009 pandemic. Criteria for ECMO institution were standardized according to national guidelines.

Results

The survival rate in patients treated with ECMO was 68 %. Significant predictors of death before ECMO instituti

SUBMITTER: Pappalardo F 

PROVIDER: S-EPMC7095375 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature